Physician profile
Robert A Goodin
NPI 1912998485
$1,535.78
in general payments reported to CMS, 2019-2025
17 companies · $408 in 2025
The $408 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $393 · 2020: $13.47 · 2021: $198 · 2022: $210 · 2023: $253 · 2024: $59.46 · 2025: $408.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $721.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $720.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zimmer Biomet Holdings, INC. | $780.77 | 2019-2025 | Persona, Oxford |
| Smith+Nephew, INC. | $192.78 | 2019-2024 | Grafix, Stravix, Oasis |
| Horizon Therapeutics Plc | $185.94 | 2019-2020 | |
| Stryker Corporation | $125.99 | 2025 | Easyfuse, Prophecy, Augment Injectable |
| Treace Medical Concepts, INC. | $60.00 | 2022 | |
| Vericel Corporation | $30.48 | 2019-2022 | |
| Heron Therapeutics, INC. | $20.99 | 2021 | |
| Amgen INC. | $19.20 | 2025 | Krystexxa |
| Abbvie INC. | $18.73 | 2021 | |
| Baudax Bio INC. | $17.26 | 2021 | |
| Boston Scientific Corporation | $16.59 | 2023 | |
| Depuy Synthes Sales INC. | $15.57 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $15.18 | 2022 | |
| Djo, LLC | $14.72 | 2024 | Cmf |
| Kowa Pharmaceuticals America, INC. | $13.89 | 2023 | Seglentis |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Orthofix Medical, INC. | $7.69 | 2019 |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Goodin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.